Hacker News Reader

Exciting pieces of research coming out right now. I could see using a blood test to find these specific biomarkers, and then getting started earlier on a drug like donanemab that has better results the earlier you start it. Combining a blood test with a preventative/early stage drug like donanemab or lecanemab would have a lot better results than just starting those immuno drugs at the first sign of symptoms.

View on HN

> a drug like donanemab that has better results the earlier you start it.

Do you think there will ever be a point where Donanemab or similar drugs will be recommended for all people after a certain age?

If I am thinking of the same medication, doesn't it have pretty nasty side-effects -- 30% chance of brain bleeding, right?

It's tough, because after a certain age, I think it would be worth the risks (in my non-medical professional opinion), but I am not sure if that is how medicine works in practice. I mean, you wouldn't want to give one medicine for a condition that he or she might never end up getting, but you probably also do not want to wait until it's too late.

I am just hoping that we find some kind of treatment in our lifetimes.

Reply on news.ycombinator.com